Towards reducing inter- and intra-observer variability: Reasons for optimism?

Affiliations

¹ Saint Luke's Mid America Heart Institute, 4401 Wornall Rd., Kansas City, MO, 64111, USA.
² Cleveland Clinic Lerner College of Medicine, Fuad Jubran Endowed Chair in Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, 9500 Euclid Ave. J1-5, Cleveland, OH, 44195, USA. JABERW@ccf.org.

Editorial

Brett W Sperry et al. J Nucl Cardiol. 2022 Apr.

. 2022 Apr;29(2):447-448.

doi: 10.1007/s12350-020-02422-8. Epub 2020 Nov 18.

¹ Saint Luke's Mid America Heart Institute, 4401 Wornall Rd., Kansas City, MO, 64111, USA.
² Cleveland Clinic Lerner College of Medicine, Fuad Jubran Endowed Chair in Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, 9500 Euclid Ave. J1-5, Cleveland, OH, 44195, USA. JABERW@ccf.org.

No abstract available

Comment on

Inter-observer reproducibility and intra-observer repeatability in ^99mTc-pyrophosphate scan interpretation for diagnosis of transthyretin cardiac amyloidosis.
Singh V, Cuddy S, Kijewski MF, Park MA, Taylor A, Taqueti VR, Skali H, Blankstein R, Falk RH, Di Carli MF, Dorbala S. Singh V, et al. J Nucl Cardiol. 2022 Apr;29(2):440-446. doi: 10.1007/s12350-020-02353-4. Epub 2020 Sep 11. J Nucl Cardiol. 2022. PMID: 32918247

1. Dorbala S, Bokhari S, Miller EJ, Bullock-Palmer R, Soman P, Thompson R. ^99mTechnetium-pyrophosphate imaging for transthyretin cardiac amyloidosis. ASNC practice points. https://www.asnc.org/Files/Practice%20Resources/Practice%20Points/ASNC%2... .
1. Dorbala S, Ando Y, Bokhari S, et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol 2019;26:2065-123. - DOI
1. Bokhari S, Morgenstern R, Weinberg R, et al. Standardization of 99mTechnetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis. J Nucl Cardiol 2018;25:181-90. - DOI
1. Sperry BW, Burgett E, Bybee KA, et al. Technetium pyrophosphate nuclear scintigraphy for cardiac amyloidosis: Imaging at 1 vs 3 hours and planar vs SPECT/CT. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol 2020;27:1802-7.
1. Masri A, Bukhari S, Ahmad S, et al. Efficient 1-Hour Technetium-99 m Pyrophosphate Imaging Protocol for the Diagnosis of Transthyretin Cardiac Amyloidosis. Circ Cardiovasc Imaging 2020;13:e010249. - DOI